Breonics
Watervliet, New York, United States
About Breonics
BREONICS’ Exsanguinous Metabolic Support (EMS) technology radically broadens the criteria for organ donors to include the huge cohort of patients that die every year and are previously not considered for donation. EMS is the first and only technology that can overcome the technical barriers that limit access to these potential donors and will more than double the number of transplantable kidneys worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Mar 2007)
- Website: breonics.com
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/breonics-2551921 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.